Intel's Q3 Test Arrives After a $30 Rebound From the Floor

Intel reports Q3 results on October 22 having clawed back roughly $2 from Monday's low, but the stock at $92.03 remains 29% below its late-September peak and down 15% on the month, the weakest setup the company has faced heading into a major print since the turnaround narrative took hold.

The most meaningful development in the past 24 hours is JP Morgan's upgrade to Neutral, which arrived on Monday as the stock was still falling. Harlan Sur lifted the rating from Underweight, ending what had been a persistently bearish stance, while holding the target at $85, well below the current price. That combination, a formal capitulation from one of the stock's longest-standing critics paired with a target that still implies downside, captures the ambivalence on the Street. The consensus sits at Hold, with Mizuho having raised its target to $114 in early October before the stock sold off further, and Piper Sandler initiating at Neutral with a $110 target in September. No analyst upgraded to Buy ahead of the print. The mean target of $117 implies meaningful upside from here, but those targets were set before the October correction.

The bull and bear cases are genuinely distinct. Bulls point to Q2 momentum: revenue up 25% to $16.1 billion, Data Center and AI revenue up 59%, foundry revenue up 31%, and gross margin improving to 41.8%. The 18A process node is executing, and platforms like Panther Lake and Xeon 6+ are validating the roadmap. Bears argue the foundry external revenue story remains thin, with modelled external customer wins producing less than $2 billion even after packaging and turnkey work. They also point to execution risk on manufacturing ramps, pricing pressure across the cycle, and the opacity of commercial terms on key programmes. The Q3 print is the first data point that will tell investors whether Q2's numbers were a trend or a peak.

The CEO's open-market purchase of 105,263 shares at $95 in August, worth $10 million and made without a 10b5-1 plan, remains the sharpest bullish signal on the insider register. Lip Bu Tan paid above Monday's close, making that bet look prescient against the current $92 level. Short interest, at 3.5% of the float, has risen about 8% over the past month and sits near the cycle high, though the lending market is entirely unconstrained: availability is effectively unlimited and cost to borrow, while up 71% on the week, amounts to just 0.39 annually. There is no squeeze pressure. Options positioning is only marginally more defensive than usual, with the put/call ratio at 0.87 against a 20-day average of 0.86, a z-score of 0.74. No meaningful hedging surge has materialised ahead of the print. The two prior earnings reactions tell a consistent story: the stock fell 8.5% in one day and 10% over five days after the July 2026 print, a pattern that puts downside discipline on anyone holding into Wednesday.

The October 22 print will test whether Intel's turnaround metrics held their momentum through Q3, and whether the foundry revenue trajectory is accelerating fast enough to justify the stock's still-elevated multiple against a sector that has been selling off hard.